Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute...

Area of Science:

• Microbiology and Immunology
• Bacteriophage Therapy
• Infectious Disease Research

Background:

• Multi-drug-resistant (MDR) bacteria pose a significant global health threat.
• Bacteriophage therapy is a promising alternative, but its mechanisms in vivo are not fully understood.
• The role of host immunity in the success of phage therapy requires elucidation.

Purpose of the Study:

• To investigate the impact of host immune components on the efficacy of phage therapy.
• To determine the mechanisms of phage-mediated bacterial clearance in acute pneumonia caused by MDR Pseudomonas aeruginosa.
• To assess the interaction between neutrophils and phages in resolving infection.

Main Methods:

• Utilized a murine model of acute pneumonia caused by MDR Pseudomonas aeruginosa.
• Compared phage therapy efficacy in healthy immunocompetent, MyD88-deficient, lymphocyte-deficient, and neutrophil-depleted mice.
• Employed population modeling to analyze in vivo results and understand infection dynamics.

Main Results:

• Neutrophil-phage synergy was essential for the resolution of pneumonia, highlighting the importance of host immunity.
• Neutrophils were critical for controlling both phage-sensitive and phage-resistant bacterial variants.
• Therapeutic phages were well-tolerated, not cleared by pulmonary immune cells, and showed no adverse effects on lung tissues.

Conclusions:

• Effective phage therapy relies on 'immunophage synergy,' where host immune cells, especially neutrophils, collaborate with phages.
• This finding challenges the traditional view that phage therapy success solely depends on bacterial susceptibility to phages.
• Phage therapy demonstrates a favorable safety profile within the pulmonary environment, supporting its therapeutic potential.